Literature DB >> 24074388

Gateway to understanding microparticles: standardized isolation and identification of plasma membrane-derived vesicles.

Sip Dinkla1, Roland Brock, Irma Joosten, Giel J C G M Bosman.   

Abstract

Microparticles (MPs) are small plasma membrane-derived vesicles that can expose molecules originating from their parental cells. As vectors of biological information they are likely to play an active role in both homeostasis and pathogenesis, making them promising biomarkers and nanomedicine tools. Therefore, there is an urgent need for standardization of MP isolation and analysis protocols to propel our understanding of MP biology to the next level. Based on current methodology and recent insights, this review proposes an optimized protocol for the isolation and biochemical characterization of MPs.

Mesh:

Substances:

Year:  2013        PMID: 24074388     DOI: 10.2217/nnm.13.149

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  21 in total

1.  Techniques for the analysis of extracellular vesicles using flow cytometry.

Authors:  Heather Inglis; Philip Norris; Ali Danesh
Journal:  J Vis Exp       Date:  2015-03-17       Impact factor: 1.355

Review 2.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

3.  Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification.

Authors:  Michal Harel; Pazit Oren-Giladi; Orit Kaidar-Person; Yuval Shaked; Tamar Geiger
Journal:  Mol Cell Proteomics       Date:  2015-01-26       Impact factor: 5.911

Review 4.  Microparticles in systemic sclerosis, targets or tools to control fibrosis: This is the question!

Authors:  Jelena Čolić; Marco Matucci Cerinic; Serena Guiducci; Nemanja Damjanov
Journal:  J Scleroderma Relat Disord       Date:  2019-06-28

5.  Acetylcholinesterase provides new insights into red blood cell ageing in vivo and in vitro.

Authors:  Joames K Freitas Leal; Merel J W Adjobo-Hermans; Roland Brock; Giel J C G M Bosman
Journal:  Blood Transfus       Date:  2017-05       Impact factor: 3.443

6.  High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.

Authors:  Antonella Caivano; Ilaria Laurenzana; Luciana De Luca; Francesco La Rocca; Vittorio Simeon; Stefania Trino; Fiorella D'Auria; Antonio Traficante; Maddalena Maietti; Tiziana Izzo; Giovanni D'Arena; Giovanna Mansueto; Giuseppe Pietrantuono; Luca Laurenti; Pellegrino Musto; Luigi Del Vecchio
Journal:  Tumour Biol       Date:  2015-07-09

7.  Monocytes of Different Subsets in Complexes with Platelets in Patients with Myocardial Infarction.

Authors:  Marina Loguinova; Natalia Pinegina; Valeria Kogan; Murad Vagida; Anush Arakelyan; Alexander Shpektor; Leonid Margolis; Elena Vasilieva
Journal:  Thromb Haemost       Date:  2018-10-09       Impact factor: 5.249

8.  Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy.

Authors:  Aleksandra Lenart-Migdalska; Leszek Drabik; Magdalena Kaźnica-Wiatr; Lidia Tomkiewicz-Pająk; Piotr Podolec; Maria Olszowska
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

9.  Abnormal red cell structure and function in neuroacanthocytosis.

Authors:  Judith C A Cluitmans; Carlo Tomelleri; Zuhal Yapici; Sip Dinkla; Petra Bovee-Geurts; Venkatachalam Chokkalingam; Lucia De Franceschi; Roland Brock; Giel J G C M Bosman
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

10.  Microparticles release by adipocytes act as "find-me" signals to promote macrophage migration.

Authors:  Akiko Eguchi; Anny Mulya; Milos Lazic; Deepa Radhakrishnan; Michael P Berk; Davide Povero; Agnieszka Gornicka; Ariel E Feldstein
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.